Wey Wen Lim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wey Wen Lim has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin John Cowling
School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region
13 shared publications - Peng Wu
World Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China
6 shared publications Dongxuan Chen
WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong , Hong Kong Special Administrative Region
5 shared publications- Eric Ho Yin Lau
University of Hong Kong
5 shared publications - Lin Wang
Department of Genetics, University of Cambridge
4 shared publications Faith Ho
School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region, China
3 shared publications
Latest Publications
- Open Access
- 26 August 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 234 (5) , e1236-e1246
Inferring Diagnostic Serial Intervals to Understand COVID-19 Transmission Dynamics in Hong Kong and Mainland China
Background: Estimating the instantaneous reproduction numbers (Rt) requires inferring generation time (GT, the interval between successive infections in the transmission chain), often approximated by the serial interval (SI, the interval between successive onsets in the transmission chain). The serial interval based on clinical outcomes is subject to recall biases, and such clinical information is not always available. As a comparable metric, we defined the diagnostic serial interval (SId, the time between diagnostic reporting of case pairs in a transmission chain) and compared it with the traditional SI. Methods: We analyzed confirmed coronavirus disease 2019 (COVID-19) cases from 3 ancestral waves in Hong Kong and the first wave in mainland China. Using Bayesian methods, we inferred the distributions of effective SI and SId, along with onset-to-reporting delays, and compared the resulting Rt estimates. Results: The distributions of SI and SId were comparable across waves, with shorter means observed in SId. Reporting delays for infectors were longer than those for infectees, which was identified as a key factor influencing the temporal variation in SI and SId. Additionally, factors such as public health and social measures, case profile, and demographics were found to significantly impact the estimates. Time-varying estimates of the reproduction number derived from both SI and SId were highly consistent, with median absolute differences ranging from 0.12 to 0.19. Conclusions: The diagnostic serial interval shows potentials as a comparable metric to the traditional serial interval for estimating transmissibility in assessing COVID-19 transmission dynamics, and this approach could be extended for other respiratory viruses.
- 26 August 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 234 (5) , e1236-e1246
Open AccessInferring Diagnostic Serial Intervals to Understand COVID-19 Transmission Dynamics in Hong Kong and Mainland China
Background: Estimating the instantaneous reproduction numbers (Rt) requires inferring generation time (GT, the interval between successive infections in the transmission chain), often approximated by the serial interval (SI, the interval between successive onsets in the transmission chain). The serial interval based on clinical outcomes is subject to recall biases, and such clinical information is not always available. As a comparable metric, we defined the diagnostic serial interval (SId, the time between diagnostic reporting of case pairs in a transmission chain) and compared it with the traditional SI. Methods: We analyzed confirmed coronavirus disease 2019 (COVID-19) cases from 3 ancestral waves in Hong Kong and the first wave in mainland China. Using Bayesian methods, we inferred the distributions of effective SI and SId, along with onset-to-reporting delays, and compared the resulting Rt estimates. Results: The distributions of SI and SId were comparable across waves, with shorter means observed in SId. Reporting delays for infectors were longer than those for infectees, which was identified as a key factor influencing the temporal variation in SI and SId. Additionally, factors such as public health and social measures, case profile, and demographics were found to significantly impact the estimates. Time-varying estimates of the reproduction number derived from both SI and SId were highly consistent, with median absolute differences ranging from 0.12 to 0.19. Conclusions: The diagnostic serial interval shows potentials as a comparable metric to the traditional serial interval for estimating transmissibility in assessing COVID-19 transmission dynamics, and this approach could be extended for other respiratory viruses.
- Open Access
- 9 July 2026
- Published by Springer Nature in npj Vaccines
- Vol. 11 (1)
Hemagglutination-inhibition and microneutralization antibody titers as mediators of protection for cell-based and recombinant influenza vaccines
The proportion of relative influenza vaccine efficacy (rVE) mediated by post-vaccination hemagglutination inhibition (HAI) and microneutralization (MN) antibody titers has not been evaluated. We compared rVE by influenza vaccine type and HAI and MN antibody titer against symptomatic influenza A(H3N2) infection in a randomized immunogenicity trial of quadrivalent cell culture-based (ccIIV4), recombinant (RIV4), and egg-based (eIIV4) influenza vaccines in US healthcare personnel, and estimated proportions of rVE mediated by antibody titers using causal mediation analysis. Cumulative influenza A(H3N2) incidence was 3.2%, 1.3% and 1% among ccIIV, eIIV4 and RIV4 recipients, respectively. Age-adjusted rVE estimates were not statistically significant. Higher MN and HAI titers against A(H3N2) vaccine and circulating viruses explained 97.9% and 15.8%, respectively, of rVE for RIV4 compared with ccIIV4, versus 1.7% and 12.6% of rVE for eIIV4 compared with ccIIV4, indicating MN titers to be used as correlates of protection against A(H3N2) for comparisons between cell-based influenza vaccines.
- 9 July 2026
- Published by Springer Nature in npj Vaccines
- Vol. 11 (1)
Open AccessHemagglutination-inhibition and microneutralization antibody titers as mediators of protection for cell-based and recombinant influenza vaccines
The proportion of relative influenza vaccine efficacy (rVE) mediated by post-vaccination hemagglutination inhibition (HAI) and microneutralization (MN) antibody titers has not been evaluated. We compared rVE by influenza vaccine type and HAI and MN antibody titer against symptomatic influenza A(H3N2) infection in a randomized immunogenicity trial of quadrivalent cell culture-based (ccIIV4), recombinant (RIV4), and egg-based (eIIV4) influenza vaccines in US healthcare personnel, and estimated proportions of rVE mediated by antibody titers using causal mediation analysis. Cumulative influenza A(H3N2) incidence was 3.2%, 1.3% and 1% among ccIIV, eIIV4 and RIV4 recipients, respectively. Age-adjusted rVE estimates were not statistically significant. Higher MN and HAI titers against A(H3N2) vaccine and circulating viruses explained 97.9% and 15.8%, respectively, of rVE for RIV4 compared with ccIIV4, versus 1.7% and 12.6% of rVE for eIIV4 compared with ccIIV4, indicating MN titers to be used as correlates of protection against A(H3N2) for comparisons between cell-based influenza vaccines.
- Open Access
- 1 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-11
Investigating setting-specific superspreading potential and generation intervals of COVID-19 in Hong Kong
Superspreading is an important feature of COVID-19 transmission dynamics, but few studies have investigated this feature stratified by transmission setting. Using detailed clustering data comprising 8647 COVID-19 cases confirmed in Hong Kong between 2020 and 2021, we estimated the mean number of new infections expected in a transmission cluster (\({C}_{Z}\)) and the degree of overdispersion (k) by setting. Estimates of \({C}_{Z}\) ranged within 0.4–7.1 across eight settings, with highest \({C}_{Z}\) in the close-social indoor setting that an average of seven new infections per cluster was expected. Transmission was most heterogeneous (k = 0.05) in retail setting and least heterogeneous (k = 1.1) in households, where smaller k indicates greater overdispersion and superspreading potential. Point-estimates of the mean generation interval (GI) ranged within 4.4–7.0, and settings with shorter mean realized GIs were associated with smaller cluster sizes. Here, we show that superspreading potential and generation intervals can vary across settings, strengthening the need for setting-specific interventions.- 1 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-11
Open AccessInvestigating setting-specific superspreading potential and generation intervals of COVID-19 in Hong Kong
Superspreading is an important feature of COVID-19 transmission dynamics, but few studies have investigated this feature stratified by transmission setting. Using detailed clustering data comprising 8647 COVID-19 cases confirmed in Hong Kong between 2020 and 2021, we estimated the mean number of new infections expected in a transmission cluster (\({C}_{Z}\)) and the degree of overdispersion (k) by setting. Estimates of \({C}_{Z}\) ranged within 0.4–7.1 across eight settings, with highest \({C}_{Z}\) in the close-social indoor setting that an average of seven new infections per cluster was expected. Transmission was most heterogeneous (k = 0.05) in retail setting and least heterogeneous (k = 1.1) in households, where smaller k indicates greater overdispersion and superspreading potential. Point-estimates of the mean generation interval (GI) ranged within 4.4–7.0, and settings with shorter mean realized GIs were associated with smaller cluster sizes. Here, we show that superspreading potential and generation intervals can vary across settings, strengthening the need for setting-specific interventions. - Open Access
- 4 November 2024
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 150, 107291
Non-pharmaceutical interventions to reduce influenza transmission in households: a systematic review and meta-analysis
- 4 November 2024
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 150, 107291
Open AccessNon-pharmaceutical interventions to reduce influenza transmission in households: a systematic review and meta-analysis
- Open Access
- 16 October 2024
- Published by Elsevier in Journal of Infection
- Vol. 89 (6) , 106315
Assessment of neutralizing antibody response as a correlate of protection against symptomatic SARS-CoV-2 infections after administration of two doses of the CoronaVac inactivated COVID-19 vaccine: A phase III randomized controlled trial
- 16 October 2024
- Published by Elsevier in Journal of Infection
- Vol. 89 (6) , 106315
Open AccessAssessment of neutralizing antibody response as a correlate of protection against symptomatic SARS-CoV-2 infections after administration of two doses of the CoronaVac inactivated COVID-19 vaccine: A phase III randomized controlled trial
- Open Access
- 12 July 2024
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 10 (1) , e49812
Predicting Efficacies of Fractional Doses of Vaccines by Using Neutralizing Antibody Levels: Systematic Review and Meta-Analysis
Background: With the emergence of SARS-CoV-2 variants that have eluded immunity from vaccines and prior infections, vaccine shortages and vaccine effectiveness pose unprecedented challenges for governments in expanding booster vaccination programs. The fractionation of vaccine doses might be an effective strategy for helping society to face these challenges, as fractional doses may have efficacies comparable with those of the standard doses. Objective: This study aims to investigate the relationship between vaccine immunogenicity and protection and to project efficacies of fractional doses of vaccines for COVID-19 by using neutralizing antibody levels. Methods: In this study, we analyzed the relationship between in vitro neutralization levels and the observed efficacies against both asymptomatic infection and symptomatic infection, using data from 13 studies of 10 COVID-19 vaccines and from convalescent cohorts. We further projected efficacies for fractional doses, using neutralization as an intermediate variable, based on immunogenicity data from 51 studies included in our systematic review. Results: In comparisons with the convalescent level, vaccine efficacy against asymptomatic infection and symptomatic infection increased from 8.8% (95% CI 1.4%-16.1%) to 71.8% (95% CI 63%-80.7%) and from 33.6% (95% CI 23.6%-43.6%) to 98.6% (95% CI 97.6%-99.7%), respectively, as the mean neutralization level increased from 0.1 to 10 folds of the convalescent level. Additionally, mRNA vaccines provided the strongest protection, which decreased slowly for fractional dosing with dosages between 50% and 100% of the standard dose. We also observed that although vaccine efficacy increased with the mean neutralization level, the rate of this increase was slower for vaccine efficacy against asymptomatic infection than for vaccine efficacy against symptomatic infection. Conclusions: Our results are consistent with studies on immune protection from SARS-CoV-2 infection. Based on our study, we expect that fractional-dose vaccination could provide partial immunity against SARS-CoV-2 and its variants. Our findings provide a theoretical basis for the efficacy of fractional-dose vaccines, serving as reference evidence for implementing fractional dosing vaccine policies in areas facing vaccine shortages and thereby mitigating disease burden. Fractional-dose vaccination could be a viable vaccination strategy comparable to full-dose vaccination and deserves further exploration.
- 12 July 2024
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 10 (1) , e49812
Open AccessPredicting Efficacies of Fractional Doses of Vaccines by Using Neutralizing Antibody Levels: Systematic Review and Meta-Analysis
Background: With the emergence of SARS-CoV-2 variants that have eluded immunity from vaccines and prior infections, vaccine shortages and vaccine effectiveness pose unprecedented challenges for governments in expanding booster vaccination programs. The fractionation of vaccine doses might be an effective strategy for helping society to face these challenges, as fractional doses may have efficacies comparable with those of the standard doses. Objective: This study aims to investigate the relationship between vaccine immunogenicity and protection and to project efficacies of fractional doses of vaccines for COVID-19 by using neutralizing antibody levels. Methods: In this study, we analyzed the relationship between in vitro neutralization levels and the observed efficacies against both asymptomatic infection and symptomatic infection, using data from 13 studies of 10 COVID-19 vaccines and from convalescent cohorts. We further projected efficacies for fractional doses, using neutralization as an intermediate variable, based on immunogenicity data from 51 studies included in our systematic review. Results: In comparisons with the convalescent level, vaccine efficacy against asymptomatic infection and symptomatic infection increased from 8.8% (95% CI 1.4%-16.1%) to 71.8% (95% CI 63%-80.7%) and from 33.6% (95% CI 23.6%-43.6%) to 98.6% (95% CI 97.6%-99.7%), respectively, as the mean neutralization level increased from 0.1 to 10 folds of the convalescent level. Additionally, mRNA vaccines provided the strongest protection, which decreased slowly for fractional dosing with dosages between 50% and 100% of the standard dose. We also observed that although vaccine efficacy increased with the mean neutralization level, the rate of this increase was slower for vaccine efficacy against asymptomatic infection than for vaccine efficacy against symptomatic infection. Conclusions: Our results are consistent with studies on immune protection from SARS-CoV-2 infection. Based on our study, we expect that fractional-dose vaccination could provide partial immunity against SARS-CoV-2 and its variants. Our findings provide a theoretical basis for the efficacy of fractional-dose vaccines, serving as reference evidence for implementing fractional dosing vaccine policies in areas facing vaccine shortages and thereby mitigating disease burden. Fractional-dose vaccination could be a viable vaccination strategy comparable to full-dose vaccination and deserves further exploration.
- Open Access
- 25 June 2024
- Published by Springer Nature in Research Square
Investigating setting-specific superspreading potential and generation intervals of COVID-19 in Hong Kong
Superspreading is an important feature of SARS-CoV-2, though few studies have investigated quantitatively how transmission characteristics can vary by setting. Using detailed clustering data comprising 8635 SARS-CoV-2 cases confirmed in Hong Kong between 2020–2021 and a negative binomial cluster size model, we estimate the mean number of new infections expected in a cluster CZ and the degree of overdispersion (k) by setting. Estimates of CZ ranged between 0.3–6.1 across eight distinct transmission settings. Close-social indoor (e.g. bars and clubs) and elderly care home settings had the highest CZ around 6, meaning for every introduction an average of six new infections is expected. Overdispersion also differed by setting, ranging from extremely heterogeneous (k = 0.05) to less heterogeneous (k = 1), and was highest in retail, close-social indoor, and care homes settings (k < 0.1), where lower values of k indicate higher superspreading potential. We found that the mean generation interval (GI) also varied by setting (range: 4.4–7.2 days), and settings with shorter mean GIs were associated with smaller cluster sizes. Our results explicitly quantify and demonstrate that superspreading potential and transmission parameters such as the GI can vary across settings, which highlights the need of setting-specific interventions for effective outbreak control.
- 25 June 2024
- Published by Springer Nature in Research Square
Open AccessInvestigating setting-specific superspreading potential and generation intervals of COVID-19 in Hong Kong
Superspreading is an important feature of SARS-CoV-2, though few studies have investigated quantitatively how transmission characteristics can vary by setting. Using detailed clustering data comprising 8635 SARS-CoV-2 cases confirmed in Hong Kong between 2020–2021 and a negative binomial cluster size model, we estimate the mean number of new infections expected in a cluster CZ and the degree of overdispersion (k) by setting. Estimates of CZ ranged between 0.3–6.1 across eight distinct transmission settings. Close-social indoor (e.g. bars and clubs) and elderly care home settings had the highest CZ around 6, meaning for every introduction an average of six new infections is expected. Overdispersion also differed by setting, ranging from extremely heterogeneous (k = 0.05) to less heterogeneous (k = 1), and was highest in retail, close-social indoor, and care homes settings (k < 0.1), where lower values of k indicate higher superspreading potential. We found that the mean generation interval (GI) also varied by setting (range: 4.4–7.2 days), and settings with shorter mean GIs were associated with smaller cluster sizes. Our results explicitly quantify and demonstrate that superspreading potential and transmission parameters such as the GI can vary across settings, which highlights the need of setting-specific interventions for effective outbreak control.
- Open Access
- 20 June 2024
- Published by Elsevier in Public Health in Practice
- Vol. 8, 100525
An observational study on imported COVID-19 cases in Hong Kong during mandatory on-arrival hotel quarantine
- 20 June 2024
- Published by Elsevier in Public Health in Practice
- Vol. 8, 100525
Open AccessAn observational study on imported COVID-19 cases in Hong Kong during mandatory on-arrival hotel quarantine
- Top Cited PapersOpen Access
- 24 August 2023
- Published by The Royal Society in Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences
- Vol. 381 (2257) , 20230132
Effectiveness of social distancing measures and lockdowns for reducing transmission of COVID-19 in non-healthcare, community-based settings
Social distancing measures (SDMs) are community-level interventions that aim to reduce person-to-person contacts in the community. SDMs were a major part of the responses first to contain, then to mitigate, the spread of SARS-CoV-2 in the community. Common SDMs included limiting the size of gatherings, closing schools and/or workplaces, implementing work-from-home arrangements, or more stringent restrictions such as lockdowns. This systematic review summarized the evidence for the effectiveness of nine SDMs. Almost all of the studies included were observational in nature, which meant that there were intrinsic risks of bias that could have been avoided were conditions randomly assigned to study participants. There were no instances where only one form of SDM had been in place in a particular setting during the study period, making it challenging to estimate the separate effect of each intervention. The more stringent SDMs such as stay-at-home orders, restrictions on mass gatherings and closures were estimated to be most effective at reducing SARS-CoV-2 transmission. Most studies included in this review suggested that combinations of SDMs successfully slowed or even stopped SARS-CoV-2 transmission in the community. However, individual effects and optimal combinations of interventions, as well as the optimal timing for particular measures, require further investigation. This article is part of the theme issue 'The effectiveness of non-pharmaceutical interventions on the COVID-19 pandemic: the evidence'.
- 24 August 2023
- Published by The Royal Society in Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences
- Vol. 381 (2257) , 20230132
Top Cited PapersOpen AccessEffectiveness of social distancing measures and lockdowns for reducing transmission of COVID-19 in non-healthcare, community-based settings
Social distancing measures (SDMs) are community-level interventions that aim to reduce person-to-person contacts in the community. SDMs were a major part of the responses first to contain, then to mitigate, the spread of SARS-CoV-2 in the community. Common SDMs included limiting the size of gatherings, closing schools and/or workplaces, implementing work-from-home arrangements, or more stringent restrictions such as lockdowns. This systematic review summarized the evidence for the effectiveness of nine SDMs. Almost all of the studies included were observational in nature, which meant that there were intrinsic risks of bias that could have been avoided were conditions randomly assigned to study participants. There were no instances where only one form of SDM had been in place in a particular setting during the study period, making it challenging to estimate the separate effect of each intervention. The more stringent SDMs such as stay-at-home orders, restrictions on mass gatherings and closures were estimated to be most effective at reducing SARS-CoV-2 transmission. Most studies included in this review suggested that combinations of SDMs successfully slowed or even stopped SARS-CoV-2 transmission in the community. However, individual effects and optimal combinations of interventions, as well as the optimal timing for particular measures, require further investigation. This article is part of the theme issue 'The effectiveness of non-pharmaceutical interventions on the COVID-19 pandemic: the evidence'.
- Open Access
- 4 November 2022
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 150, 1-30
The impact of repeated vaccination on relative influenza vaccine effectiveness among vaccinated adults in the United Kingdom
Annual seasonal influenza vaccination is recommended for individuals at high risk of developing post-infection complications in many locations. However, reduced vaccine immunogenicity and effectiveness have been observed among repeat vaccinees in some influenza seasons. We investigated the impact of repeated influenza vaccination on relative vaccine effectiveness (VE) among individuals who were recommended for influenza vaccination in the United Kingdom with a retrospective cohort study using primary healthcare data from the Clinical Practice Research Datalink, a primary care database in the United Kingdom. Relative VE was estimated against general practitioner-diagnosed influenza-like illnesses (GP-ILI) and medically attended acute respiratory illnesses (MAARI) among participants who have been repeatedly vaccinated compared with first-time vaccinees using proportional hazards models. Relative VE against MAARI may be reduced for individuals above 65 years old who were vaccinated in the current and previous influenza seasons for some influenza seasons. However, these findings were not conclusive as we could not exclude the possibility of residual confounding in our dataset. The use of routinely collected data from electronic health records to examine the effects of repeated vaccination needs to be complemented with sufficient efforts to include negative control outcomes to rule out residual confounding.
- 4 November 2022
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 150, 1-30
Open AccessThe impact of repeated vaccination on relative influenza vaccine effectiveness among vaccinated adults in the United Kingdom
Annual seasonal influenza vaccination is recommended for individuals at high risk of developing post-infection complications in many locations. However, reduced vaccine immunogenicity and effectiveness have been observed among repeat vaccinees in some influenza seasons. We investigated the impact of repeated influenza vaccination on relative vaccine effectiveness (VE) among individuals who were recommended for influenza vaccination in the United Kingdom with a retrospective cohort study using primary healthcare data from the Clinical Practice Research Datalink, a primary care database in the United Kingdom. Relative VE was estimated against general practitioner-diagnosed influenza-like illnesses (GP-ILI) and medically attended acute respiratory illnesses (MAARI) among participants who have been repeatedly vaccinated compared with first-time vaccinees using proportional hazards models. Relative VE against MAARI may be reduced for individuals above 65 years old who were vaccinated in the current and previous influenza seasons for some influenza seasons. However, these findings were not conclusive as we could not exclude the possibility of residual confounding in our dataset. The use of routinely collected data from electronic health records to examine the effects of repeated vaccination needs to be complemented with sufficient efforts to include negative control outcomes to rule out residual confounding.